Literature DB >> 28509251

Increased antiangiogenetic factors in severe proteinuria without hypertension in pregnancy: is kidney biopsy necessary?

Takako Ohmaru1, Akihide Ohkuchi2, Shigeaki Muto3, Chikako Hirashima1, Shigeki Matsubara1, Mitsuaki Suzuki1.   

Abstract

Acute onset of severe proteinuria during pregnancy obliges physicians to clinically discriminate between gestational proteinuria (GP) and new onset of nephritis. A multiparous woman developed severe proteinuria (5.8 g/day) without hypertension at 32 weeks of gestation. We measured the maternal level of soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sEng), which were extremely high (41.3 and 54.8 ng/ml, respectively), leading us to consider this condition as GP rather than acute onset of nephritis. Thus, we did not perform a kidney biopsy and did not administer a steroid agent. Non-reassuring fetal status required emergency Cesarean section at 33 weeks. Proteinuria decreased to 0.36 g/day at 12 weeks after delivery, and finally disappeared 26 weeks postpartum. Measurement of sFlt-1 and sEng in a pregnant woman with severe proteinuria without hypertension may assist in differential diagnosis of GP from acute onset of nephritis, and thus help to decide whether to perform kidney biopsy during pregnancy.

Entities:  

Keywords:  Gestational proteinuria; Nephritis; Pregnancy; Soluble endoglin; Soluble fms-like tyrosine kinase 1

Year:  2013        PMID: 28509251      PMCID: PMC5413678          DOI: 10.1007/s13730-013-0092-z

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  12 in total

1.  Gestational hypertension as a subclinical preeclampsia in view of serum levels of angiogenesis-related factors.

Authors:  Chikako Hirashima; Akihide Ohkuchi; Kayo Takahashi; Hirotada Suzuki; Mika Yoshida; Takako Ohmaru; Kazuo Eguchi; Haruko Ariga; Shigeki Matsubara; Mitsuaki Suzuki
Journal:  Hypertens Res       Date:  2010-11-04       Impact factor: 3.872

2.  Threshold of soluble fms-like tyrosine kinase 1/placental growth factor ratio for the imminent onset of preeclampsia.

Authors:  Akihide Ohkuchi; Chikako Hirashima; Shigeki Matsubara; Kayo Takahashi; Yoshio Matsuda; Mitsuaki Suzuki
Journal:  Hypertension       Date:  2011-09-26       Impact factor: 10.190

3.  Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

Authors:  Richard J Levine; Chun Lam; Cong Qian; Kai F Yu; Sharon E Maynard; Benjamin P Sachs; Baha M Sibai; Franklin H Epstein; Roberto Romero; Ravi Thadhani; S Ananth Karumanchi
Journal:  N Engl J Med       Date:  2006-09-07       Impact factor: 91.245

4.  Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis.

Authors:  Hisashi Masuyama; Naoko Suwaki; Hideki Nakatsukasa; Akio Masumoto; Yoko Tateishi; Yuji Hiramatrsu
Journal:  Am J Obstet Gynecol       Date:  2006-02       Impact factor: 8.661

Review 5.  Kidney biopsy in pregnancy: evidence for counselling? A systematic narrative review.

Authors:  G B Piccoli; G Daidola; R Attini; S Parisi; F Fassio; C Naretto; M C Deagostini; N Castelluccia; M Ferraresi; D Roccatello; T Todros
Journal:  BJOG       Date:  2013-01-15       Impact factor: 6.531

6.  Postpartum persistent proteinuria after preeclampsia: a single-center experience.

Authors:  Selman Unverdi; Mevlut Ceri; Hatice Unverdi; Rahmi Yilmaz; Ali Akcay; Murat Duranay
Journal:  Wien Klin Wochenschr       Date:  2013-01-19       Impact factor: 1.704

7.  Effect of recombinant placental growth factor 2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant mice.

Authors:  Hirotada Suzuki; Akihide Ohkuchi; Shigeki Matsubara; Yuji Takei; Masato Murakami; Masabumi Shibuya; Mitsuaki Suzuki; Yasufumi Sato
Journal:  Hypertension       Date:  2009-09-28       Impact factor: 10.190

8.  Circulating angiogenic factors and the risk of preeclampsia.

Authors:  Richard J Levine; Sharon E Maynard; Cong Qian; Kee-Hak Lim; Lucinda J England; Kai F Yu; Enrique F Schisterman; Ravi Thadhani; Benjamin P Sachs; Franklin H Epstein; Baha M Sibai; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

9.  Pregnancy outcome of women who developed proteinuria in the absence of hypertension after mid-gestation.

Authors:  Mamoru Morikawa; Takashi Yamada; Takahiro Yamada; Kazutoshi Cho; Hideto Yamada; Noriaki Sakuragi; Hisanori Minakami
Journal:  J Perinat Med       Date:  2008       Impact factor: 1.901

10.  Alteration of serum soluble endoglin levels after the onset of preeclampsia is more pronounced in women with early-onset.

Authors:  Chikako Hirashima; Akihide Ohkuchi; Shigeki Matsubara; Hirotada Suzuki; Kayo Takahashi; Rie Usui; Mitsuaki Suzuki
Journal:  Hypertens Res       Date:  2008-08       Impact factor: 3.872

View more
  1 in total

1.  Clinical usefulness of serum levels of soluble fms-like tyrosine kinase 1/placental growth factor ratio to rule out preeclampsia in women with new-onset lupus nephritis during pregnancy.

Authors:  Chikako Hirashima; Manabu Ogoyama; Miyuki Abe; Satoru Shiraishi; Taro Sugase; Toshiro Niki; Shigeki Matsubara; Akihide Ohkuchi
Journal:  CEN Case Rep       Date:  2018-12-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.